Pierre Fumoleau

Pierre Fumoleau

UNVERIFIED PROFILE

Are you Pierre Fumoleau?   Register this Author

Register author
Pierre Fumoleau

Pierre Fumoleau

Publications by authors named "Pierre Fumoleau"

Are you Pierre Fumoleau?   Register this Author

100Publications

3473Reads

45Profile Views

Clinical value of CA 15-3 for detection of distant metastases in newly diagnosed breast cancer.

Ann Biol Clin (Paris) 2017 Aug;75(4):421-429

Département de biologie et pathologie des tumeurs, Centre Georges François Leclerc, Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/abc.2017.1257DOI Listing
August 2017

Exosomes in cancer theranostic: Diamonds in the rough.

Cell Adh Migr 2017 03 6;11(2):151-163. Epub 2017 Feb 6.

a INSERM, UMR 866, Laboratoire d'Excellence LipSTIC , Dijon , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/19336918.2016.1250999DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351734PMC
March 2017

[The anti-tumor immune response in breast cancer: Update and therapeutic perspectives].

Ann Pathol 2017 Feb 31;37(1):133-141. Epub 2017 Jan 31.

Département d'oncologie médicale, centre Georges-François-Leclerc, 21000 Dijon, France; Plateforme de transfert en biologie cancérologique, centre Georges-François-Leclerc, 21000 Dijon, France; UMR Inserm U866, faculté de médecine de Dijon, 21000 Dijon, France; UFR des sciences de santé, 21000 Dijon, France; Université de Bourgogne, 21000 Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2016.12.012DOI Listing
February 2017

[CEA and early detection of relapse in breast cancer subtypes: Comparison with CA 15-3].

Bull Cancer 2016 May 8;103(5):434-43. Epub 2016 Mar 8.

Centre Georges-François-Leclerc, département d'oncologie médicale, 1, rue de Pr.-Marion, 21079 Dijon cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.02.003DOI Listing
May 2016

Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer.

J Natl Cancer Inst 2016 Mar 22;108(3). Epub 2015 Nov 22.

Affiliations of authors:INSERM, UMR 866, Laboratoire d'Excellence LipSTIC , Dijon , France (JG, GM, MC, AMMD, NP, AH, SR, HM, NI, VC, CR, FL, FG, AdT, RS, CG); Faculty of Medicine and Pharmacy, University of Burgundy , Dijon , France (JG, GM, MC, AMMD, NP, AH, SR, HM, NI, VC, CR, FL, FG, AdT, RS, CG); Department of Medical Oncology, Georges-François Leclerc Centre , Dijon , France (JG, NI, CR, AB, VG, FG, PF, CG); Department of Biostatistics, Georges-François Leclerc Centre , Dijon , France (AB); CHU , Dijon , France (FL); Equipe Labellisée par la Ligue Nationale contre le Cancer (CG).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/108/3/djv330.full.pdf
Web Search
http://jnci.oxfordjournals.org/lookup/doi/10.1093/jnci/djv33
Publisher Site
http://dx.doi.org/10.1093/jnci/djv330DOI Listing
March 2016

Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.

Clin Cancer Res 2015 Dec 30;21(24):5460-8. Epub 2015 Jun 30.

Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France. Université de Bourgogne, UMR CNRS 6306, Dijon, France. Imaging Department, CHU Le Bocage, Dijon, France.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-15-0384DOI Listing
December 2015

Challenges in the implementation of trastuzumab biosimilars: an expert panel's recommendations.

Anticancer Drugs 2015 Nov;26(10):1009-16

aDepartment of Medical Oncology, University Hospital Jean Minjoz, Besançon bFaculty of Pharmacy of Lyon cLéon Bérard Cancer Center, Lyon dGeorge François Leclerc Cancer Center, Dijon eDeparment of Radiotherapy, University Hospital Tenon, Paris fFSNB Health & Care, Paris gDepartment of Pharmacy, University Hospital Jean Minjoz, Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000287DOI Listing
November 2015

[Clinical value of CA 15-3 for early detection of relapse in locally advanced breast cancer].

Bull Cancer 2015 Oct 28;102(10):834-44. Epub 2015 Sep 28.

Centre Georges-François-Leclerc, département de biologie et pathologie des tumeurs, 1, rue de Pr.-Marion, 21079 Dijon cedex, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2015.07.011DOI Listing
October 2015

Role of positron emission tomography for the monitoring of response to therapy in breast cancer.

Oncologist 2015 Feb 5;20(2):94-104. Epub 2015 Jan 5.

Departments of Nuclear Medicine and Medical Oncology, Centre G.F. Leclerc, Dijon, France; Imaging Department, Centre Hospitalo-Universitaire Le Bocage, Dijon, France; Université de Bourgogne, UMR CNRS 6306, Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0342DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319634PMC
February 2015

Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions?

Crit Rev Oncol Hematol 2014 Dec 30;92(3):235-57. Epub 2014 Jul 30.

University Institute of Pathology, CHUV, rue du Bugnon 25, 1011 Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2014.07.003DOI Listing
December 2014

A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study).

Breast 2014 Oct 24;23(5):663-9. Epub 2014 Jul 24.

Institut Jules Bordet, Boulevard de Waterloo 121, 1000 Brussels, Belgium; Institut Jules Bordet (currently at Champalimaud Cancer Center), Av. de Brasília, s/n, 1400-038 Lisbon, Portugal. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2014.07.003DOI Listing
October 2014

Next-generation sequencing analysis of lung and colon carcinomas reveals a variety of genetic alterations.

Int J Oncol 2014 Sep 27;45(3):1167-74. Epub 2014 Jun 27.

Department of Biology and Pathology of Tumors, Centre Georges-François Leclerc, 21079 Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2014.2528DOI Listing
September 2014

Effect of obesity on disease-free and overall survival in node-positive breast cancer patients in a large French population: a pooled analysis of two randomised trials.

Eur J Cancer 2014 Feb 4;50(3):506-16. Epub 2013 Dec 4.

Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France; Institut National de la Santé et de la Recherche Médicale (INSERM), CRI-866 Faculty of Medicine, Dijon, France; University of Burgundy, Dijon, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2013.11.013DOI Listing
February 2014

Pathological response and survival after neoadjuvant therapy for breast cancer: a 30-year study.

Breast 2013 Jun 3;22(3):301-8. Epub 2012 Aug 3.

Department of Medical Oncology, Georges-François Leclerc Cancer Center, Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2012.07.012DOI Listing
June 2013

The paradox of triple negative breast cancer: novel approaches to treatment.

Breast J 2012 Jan-Feb;18(1):41-51. Epub 2011 Nov 20.

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York City, New York, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1524-4741.2011.01175.x
Publisher Site
http://dx.doi.org/10.1111/j.1524-4741.2011.01175.xDOI Listing
September 2012

Feasibility and safety of weekly sequential epirubicin-paclitaxel as adjuvant treatment for operable breast cancer patients older than 70 years.

Clin Breast Cancer 2011 Aug 7;11(4):235-40. Epub 2011 Jul 7.

Department of Medical Oncology, Georges François Leclerc Center, Centrede Recherche INSERM 866, Faculté de Médecine, 7 Boulevard Jeanne d’Arc, Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2011.06.002DOI Listing
August 2011

In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival.

J Pathol 2011 Jul 25;224(3):389-400. Epub 2011 Mar 25.

Department of Medical Oncology, Georges François Leclerc Center, Dijon, France; Institut National de la Santé et de la Recherche Médicale, Avenir Team INSERM, CRI-866 University of Burgundy, Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.2866DOI Listing
July 2011

Variations in gene expression and response to neoadjuvant chemotherapy in breast carcinoma.

Cancer Invest 2009 Jun;27(5):521-8

Laboratory of Molecular Genetics, Centre Georges Francois Leclerc, UMR-INSERM U-866, Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357900802298096DOI Listing
June 2009

Results of a phase I trial of intravenous vinorelbine plus oral capecitabine as first-line chemotherapy of metastatic breast cancer.

Breast 2008 Feb 14;17(1):36-41. Epub 2007 Aug 14.

Department of Medical Oncology, Centre Georges-François Leclerc, 1 rue du Professeur Marion, 21000 Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2007.06.003DOI Listing
February 2008

[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy.

Eur J Nucl Med Mol Imaging 2007 Dec 20;34(12):1915-24. Epub 2007 Jun 20.

Department of Nuclear Medicine, Centre Georges Francois Leclerc, Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-007-0459-5DOI Listing
December 2007

[Targeting ErbB receptors in breast cancer].

Bull Cancer 2007 ;94(7 Suppl):F147-70

Centre Georges-François Leclerc, rue du Professeur Marion, 21079 Dijon.

View Article

Download full-text PDF

Source
December 2007

[Angiogenesis targeting in breast cancer].

Bull Cancer 2007 ;94(7 Suppl):F199-206

Centre Georges-François Leclerc, rue du Professeur-Marion, 21079 Dijon.

View Article

Download full-text PDF

Source
December 2007

Pharmacokinetics of tipifarnib after oral and intravenous administration in subjects with advanced cancer.

J Clin Pharmacol 2006 Oct;46(10):1116-27

Johnson & Johnson Pharmaceutical Research & Development, Titusville, New Jersey, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0091270006291034DOI Listing
October 2006

Phase I study of vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeks.

Invest New Drugs 2006 May;24(3):223-31

Cancer Research UK Oncology Unit, Southampton University Hospitals, Southampton, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-005-3902-0DOI Listing
May 2006

Adaptation and performance of an immuno-PCR assay for the quantification of Aviscumine in patient plasma samples.

J Pharm Biomed Anal 2005 Oct 27;39(5):972-82. Epub 2005 Jun 27.

Chimera Biotec GmbH, Emil-Figge-Str. 76 A, D-44227 Dortmund, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpba.2005.04.051DOI Listing
October 2005

Taxanes in adjuvant breast cancer setting: which standard in Europe?

Crit Rev Oncol Hematol 2005 Sep;55(3):167-75

Centre René Gauducheau, Boulevard Jacques Monod, 44 805 Nantes Cedex/Saint Herblain, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2005.04.003DOI Listing
September 2005

The vital role of education and information in patients receiving capecitabine (Xeloda).

Eur J Oncol Nurs 2004 ;8 Suppl 1:S41-53

Department of Medicine, Royal Marsden Hospital, Fulham Road, London and Surrey, SW3 6JJ, UK.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S146238890400055
Publisher Site
http://dx.doi.org/10.1016/j.ejon.2004.06.008DOI Listing
November 2004

[Cardiac dysfunction induced by trastuzumab].

Bull Cancer 2004 Nov;91 Suppl 3:166-73

Centre René-Gauducheau, Boulevard Jacques-Monod, 44805 Nantes Cedex.

View Article

Download full-text PDF

Source
November 2004

Future options with capecitabine (Xeloda) in (neo)adjuvant treatment of breast cancer.

Semin Oncol 2004 Oct;31(5 Suppl 10):45-50

Centre Georges-François Leclerc, Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2004.07.021DOI Listing
October 2004